ROP
62
-3
MLM
63
-4
DTE
40
6
FOX
53
2
LB
49
-33
MSFT
51
-4
HRB
65
6
MS
81
2
AIZ
73
-3
TSCO
53
-5
AMAT
49
-3
PYPL
62
10
FDX
44
-7
URBN
67
5
PFG
48
5
NOC
56
2
PSA
58
-2
XRAY
17
-12
TGT
49
5
AA
57
-6
ROP
62
-3
MLM
63
-4
DTE
40
6
FOX
53
2
LB
49
-33
MSFT
51
-4
HRB
65
6
MS
81
2
AIZ
73
-3
TSCO
53
-5
AMAT
49
-3
PYPL
62
10
FDX
44
-7
URBN
67
5
PFG
48
5
NOC
56
2
PSA
58
-2
XRAY
17
-12
TGT
49
5
AA
57
-6
Financhill
Back

Caribou Biosciences 10K Form

Buy
67

CRBU
Caribou Biosciences

Last Price:
2.35
Seasonality Move:
-3.22%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CRBU News And Ratings

See the #1 stock for the next 7 days that we like better than CRBU

CRBU Financial Statistics

Sales & Book Value

Annual Sales: $34.48M
Cash Flow: $-33.33M
Price / Cash Flow: 0
Annual Sales: $3.11
Price / Book: 0.9

Profitability

EPS (TTM): -1.66000
Net Income (TTM): $-148.12M
Gross Margin: --
Return on Equity: -43.52%
Return on Assets: -36.78%

Caribou Biosciences Earnings Forecast

Key Caribou Biosciences Financial Ratios

  • The Research & Development expenses have been 325.07% of Revenue.
  • The Interest Expense is -0.01% of Operating Income.
  • The Net Earning history of CRBU is -296.05% of Total Revenues.
  • Per Share Earnings over the last 5 years have been positive in 2 years.

Caribou Biosciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: CRBU
Website: cariboubio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 7.38
Quick Ratio: 7.18

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

CRBU Technical Analysis vs Fundamental Analysis

Buy
67
Caribou Biosciences (CRBU) is a Buy

Is Caribou Biosciences a Buy or a Sell?